Background: Till today cancer is still challenging to treat and needs more active therapeutic
approaches. Participation of complex multi-pathway cell propagation instrument is a noteworthy
issue in creating active anticancer therapeutic methodologies. Immune evasions, metabolic
modifications, imperfect apoptotic component, modification in upstream or downstream RAS signaling,
altered nuclear factor kappa B actions, imbalanced autophagy design and distortedly controlled
angiogenesis are distinguishing features of cancer.
Method: On the basis of systemic research and analysis of the current online available database,
we analyzed and reported about the key signaling pathway engaged with cancer development outlining
the effectiveness of different therapeutic measures and targets that have been created or are
being researched to obstruct the cancer development.
Results: A number of signaling pathways, for example, resistant, metabolism, apoptosis, RAS
protein, nuclear factor kappa B, autophagy, and angiogenesis have been perceived as targets for
drug treatment to control the advancement, development and administration of cancer.
Conclusion: A noteworthy challenge for future medication advancement is to detail a synthesis
treatment influencing distinctive targets to enhance the treatment of cancer.